Inactivation of endothelial derived relaxing factor by oxidized lipoproteins

Journal of Clinical Investigation

Volumn 89, Issue 1, 1992, Pages 10-18

  Chin, Jane H ^a   Azhar, Salman ^a   Hoffman, Brian B ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

Bradykinin; EDRF; Lipoproteins; Nitric oxide

Indexed keywords

CYCLIC GMP; ENDOTHELIUM DERIVED RELAXING FACTOR; LIPOPROTEIN; NITRIC OXIDE;

ANIMAL TISSUE; ARTICLE; COW; ENDOTHELIUM CELL; NONHUMAN; PRIORITY JOURNAL;

ANIMAL; AORTA; BRADYKININ; CALCIMYCIN; CATTLE; CYCLIC GMP; ENDOTHELIUM, VASCULAR; FIBROBLASTS; FREE RADICALS; LIPOPROTEINS, LDL; LUNG; NITRIC OXIDE; OXIDATION-REDUCTION; OXYGEN; RATS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0026570225     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI115549     Document Type: Article

References (21)

1. Furchgott, R. F., and J. V. Zawadzki. 1980. The obligator, role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature (Lond.). 288:373-376.
2. Furchgott, R. F., and P. M. Vanhoutte. 1989. Endothelium-derived relaxing and contracting factors. FASEB (Fed. Am. Soc. Exp. Biol.) J. 3:2007-2018.
3. Moncada, S., M. W. Radomski, and R. M. J Palmer. 1988. Endothelium-derived relaxing factor. Identification as nitric oxide and role in the control of vascular tone and platelet function. Biochem. Pharmacol. 37:2495-2501.
4. Palmer, R. M. J., D. S. Ashton, and S. Moncada. 1988. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature (Lond). 333:664-666.
5. Palmer, R. M. J., and S. Moneada, 1989. A novel citrulline-forming enzyme implicated in the formation of nitric oxide by vascular endothelial cells. Biochem. Biophys. Res. Commun. 158:348-352.
6. Ignarro, L. J. 1990. Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu. Rev. Pharmacol. Toxicol. 30:535-560.
7. Rapoport, R. M., and F. Murad. 1988. Role of cyclic GMP in endothelium-dependent relaxation of vascular smooth muscle. In Relaxing and Contracting Factors. P. M. Vanhoutte, editor. Humana Press, Clifton, NJ. 219-239.
8. Ignarro, L. J. 1990. Nitric oxide. A novel signal transduction mechanism for transcellular communication. Hypertension (Dallas). 16:477-483.
9. Ishii, K., L. D. Gorsky U. Förstermann, and F. Murad. 1989. Endothelium-derived relaxing factor (EDRF): the endogenous activator of soluble guanylate cyclase in various types of cells. J. Appl. Cardiol. 4:505-512.
10. Moncada, S., R. M. J. Palmer, and E. A. Higgs. 1991. Nitric oxide: physiology. pathophysiology, and pharmacology. Pharmacol. Rev. 43:109-142.
11. Andrews, H. E., K. R. Bruckdorfer, R. C. Dunn, and M. Jacobs. 1987. Low-density lipoproteins inhibit endothelium-dependent relaxation in rabbit aorta, Nature (Lond.). 327:237-239.
12. Jacobs, M., F. Plane, and K. R. Bruckdorfer, 1990. Native and oxidized low-density lipoproteins have different inhibitory effects on endothelium-derived relaxing factor in the rabbit aorta. Br J. Pharmacol. 100:21-26.
13. Kugiyama, K., S. A. Kerns, J. D. Morrisett, R. Roberts, and P. D. Henry. 1990. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature (Lond.). 344:160-162.
14. Takahashi, M., Y. Yui, H. Yasumoto, T. Aoyama, H. Morishita, R. Hattori, and C. Kawai. 1990. Lipoproteins are inhibitors of endothelium-dependent relaxation of rabbit aorta. Am. J. Physiol. 258 (Heart Circ. Physiol. 27):H1-H8.
15. Tomita, T., M. Ezaki, M. Miwa, K. Nakamura, and Y. Inoue, 1990. Rapid and reversible inhibition by low density lipoprotein of the endothelium-dependent relaxation to hemostatic substances in porcine coronary arteries. Heat and acid labile factors in low density lipoprotein mediate the inhibition. Circ. Res. 66:18-27.
16. Steinberg, D., S. Parthasarathy, T. E. Carew, J. C. Khoo, and J. L. Witzum. 1989. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320:915-924.
17. Verbeuren, T. J., F. H. Jordaens, L. L. Zonnekeyn, C. E. Van Hove, M.-C. Coene, and A. G. Herman. 1986. Effect of hypercholesterolemia on vascular reactivity in the rabbit. Circ: Res. 58:552-564.
18. Verbeuren, T. J., F. H. Jordaens, C. E. Van Hove, A.-E. Van Hoydonck, and A. G. Herman. 1990. Release and vascular activity of endothelium-derived relaxing factor in atherosclerotic rabbit aorta. Eur. J. Pharmacol. 191:173-184.
19. Bossaller, C., G. B. Habib, H. Yamamoto, C. Williams, S. Wells, and P. D. Henry, 1987. Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5′-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta. J. Clin. Invest. 79:170-174.
20. Förstermann, U., A. Mügge, U. Alheid, A. Haverich, and Jürgen C. Frölich. 1988. Selective attenuation of endothelium-mediated vasodilation in atherosclerotic human coronary arteries. Circ. Res. 62:185-190.
21. Creager, M. A., J. P. Cooke, M. E. Mendelsohn, S. J. Gallagher, S. M. Coleman, J. Loscalzo, and V. J. Dzau. 1990. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J. Clin. Invest. 86:228-234.